Utilization, safety, and tolerability of ocrelizumab: year 2 data from the Providence Ocrelizumab Registry

Authors

• Kyle E Smoot, Providence Multiple Sclerosis Center, Providence Health & Services, 9427 SW Barnes Road, Portland, OR 97225, USA; Providence Brain and Spine Institute, Providence Health & Services, 9135 SW Barnes Road, Suite 461, Portland, OR 97225, USAFollow

Document Type

Article

Publication Date

2019

Keywords

oregon; providence neuroscience institute

Area of Special Interest

Neurosciences (Brain & Spine)

Specialty/Research Institute

Neurosciences